LianBio (LIANY)
OTCMKTS
· Delayed Price · Currency is USD
0.3700
+0.0100 (2.78%)
Jun 2, 2025, 3:02 PM EDT
LianBio Market Cap
LianBio has a market cap or net worth of $40.02 million as of June 2, 2025. Its market cap has increased by 16.94% in one year.
Market Cap
40.02M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.37
Market Cap Chart
Since November 1, 2021, LianBio's market cap has decreased from 1.44B to 40.02M, a decrease of -97.22%. That is a compound annual growth rate of -63.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 30, 2025 | 38.94M | 35.85% |
| Dec 31, 2024 | 28.66M | -94.07% |
| Dec 29, 2023 | 483.04M | 171.83% |
| Dec 30, 2022 | 177.70M | -73.10% |
| Dec 31, 2021 | 660.59M | -54.19% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 1.60B |
| Veradigm | 730.27M |
| Nika Pharmaceuticals | 667.04M |
| Tian'an Technology Group | 614.49M |
| Elite Pharmaceuticals | 576.87M |
| Glass House Brands | 452.99M |
| CytoDyn | 427.05M |
| Northwest Biotherapeutics | 394.36M |